Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers

Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers

Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomark...

Full description

Bibliographic Details
Main Authors:	Mythily Srinivasan, Melinda L. Meadows, Lisa Maxwell
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Biochemistry Research International
Online Access:	http://dx.doi.org/10.1155/2018/7463796

Similar Items

Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic Dermatitis
by: Edyta Machura, et al.
Published: (2013-01-01)

Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus
by: Ahmed Tijani Bawah, et al.
Published: (2019-12-01)

BIOLOGICAL ASSOCIATIONS BETWEEN RESISTIN, ADIPONECTIN, VISFATIN AND GHRELIN HORMONES WITH SOME COAGULATION MARKERS
by: Zh. Sh. Hayder, et al.
Published: (2021-02-01)

Serum Adipocytokines (Visfatin and Resistin): New Biomarkers of Breast Carcinogenesis
by: Sanaa A. El-Benhawy, et al.
Published: (2015-10-01)

Literature–Based Discovery of Salivary Biomarkers for Type 2 Diabetes Mellitus
by: Mythily Srinivasan, et al.
Published: (2015-01-01)

Literature-Based Discovery of Salivary Biomarkers for Type 2 Diabetes Mellitus
by: Mythily Srinivasan, et al.
Published: (2015-05-01)

Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models
by: Anthony Estienne, et al.
Published: (2019-09-01)

An Evaluation of Serum and Salivary Adipokines (Leptin and Resistin) Levels in Periodontal Health and Disease
by: Talib A Karam, et al.
Published: (2015-12-01)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Tania Romacho, et al.
Published: (2013-01-01)

Serum visfatin in type 2 diabetes mellitus
by: Samiha A. Abd Rabo, et al.
Published: (2013-01-01)

Association of Adipokine Resistin With Homeostasis Model Assessment of Insulin Resistance in Type II Diabetes
by: Sokhanguei, et al.
Published: (2015-03-01)

Measurement of Salivary Resistin Level in Patients with Type 2 Diabetes
by: Jinhua Yin, et al.
Published: (2012-01-01)

Analysis of the chemerin and resistin adipokines in children and adolescents
by: Vanessa S. Fontes, et al.

The levels of resistin and other adipokines in patients with hypothyroidism
by: N I Verbovaia, et al.
Published: (2014-10-01)

The effects of the adipocyte-secreted proteins resistin and visfatin on the pancreatic beta-cell
by: Onyango, David J.
Published: (2009)

Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin
by: Saisudha Koka, et al.
Published: (2019-08-01)

Resistin: A Potential Biomarker for Periodontitis Influenced Diabetes Mellitus and Diabetes Induced Periodontitis
by: Archana Devanoorkar, et al.
Published: (2014-01-01)

Visfatin and adiponectin as early markers of atherosclerosis in type 2 diabetes mellitus
by: Ibtissam Zakaria, et al.
Published: (2013-01-01)

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
by: Mehmet Yalniz, et al.
Published: (2006-01-01)

Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma
by: Nieminen Riina, et al.
Published: (2011-05-01)

RESISTIN, AN ADIPOKINE WITH NON-GENERALISED ACTIONS ON SYMPATHETIC NERVE ACTIVITY
by: Emilio eBadoer, et al.
Published: (2015-11-01)

Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes
by: Lili Deng, et al.
Published: (2020-05-01)

The impact of serum visfatin, and resistin levels on insulin resistance in patients with polycystic ovary syndrome
by: Shatha Rouf Moustafa, et al.
Published: (2020-06-01)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
by: Mengni Li, et al.
Published: (2021-09-01)

Effects of canagliflozin versus glimepiride on adipokines, inflammatory biomarkers, and chemokines in patients with type 2 diabetes mellitus
by: W.T. Garvey, et al.
Published: (2017-11-01)

Resistin, Visfatin, Adiponectin, and Leptin: Risk of Breast Cancer in Pre- and Postmenopausal Saudi Females and Their Possible Diagnostic and Predictive Implications as Novel Biomarkers
by: Adel M. A. Assiri, et al.
Published: (2015-01-01)

The content of adipokines in women with hypothyroidism and type 2 diabetes mellitus
by: A. F. Verbovoy, et al.
Published: (2021-01-01)

Adipokines and their possible role in obesity and type 2 diabetes mellitus
by: Kuznetsova L.A., et al.
Published: (2018-06-01)

The role of adipokines in gestational diabetes mellitus
by: Marwa R. Al-Badri, et al.
Published: (2015-06-01)

Resistin , Insulin resistance and BMI in type 2 diabetes mellitus and healthy subjects.
by: Zainab A. Al-Shamma, et al.
Published: (2008-10-01)

Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus
by: Elsehmawy AAEW, et al.
Published: (2019-03-01)

Adiponectin, Omentin, Ghrelin, and Visfatin Levels in Obese Patients with Severe Obstructive Sleep Apnea
by: Dong-mei Zhang, et al.
Published: (2018-01-01)

A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures
by: Sara Cheleschi, et al.
Published: (2018-12-01)

Effect of One Course Pilates Exercise Program on Serum Levels of Resistin, Visfatin, and Chemerin in Overweight Women
by: Mojdeh KhajehLandi, et al.
Published: (2020-12-01)

Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity
by: Ursavas Ahmet, et al.
Published: (2010-01-01)

The relationship between resistin and ghrelin levels with fibrosis in nonalcoholic fatty liver disease
by: Ahmet Tarık Eminler, et al.
Published: (2014-01-01)

Salivary inflammatory biomarkers and glycated haemoglobin among patients with type 2 diabetic mellitus
by: Ekhosuehi Theophilus Agho, et al.
Published: (2021-03-01)

Serum resistin and adiponectin relationships with glucometabolic control in patients with type 2 diabetes mellitus
by: Al Regaeiy Khlalid A., et al.
Published: (2018-01-01)

INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: A. T. Teplyakov, et al.
Published: (2015-10-01)

Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
by: Al-Harithy Rowyda, et al.
Published: (2005-01-01)